Cargando…
The use of isCGM leads to marked reduction in severe hypoglycemia requiring emergency medical service or hospital admission and diabetic ketoacidosis in adult type 1 diabetes patients
AIMS: To determine the effect of the use of intermittently scanned continuous glucose monitoring (isCGM) on acute diabetes-related complications in adult type 1 diabetes patients. METHODS: Six hundred and forty-two adult type 1 diabetes patients with isCGM were identified from electronic health reco...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198841/ https://www.ncbi.nlm.nih.gov/pubmed/36977968 http://dx.doi.org/10.1007/s00592-023-02079-y |
_version_ | 1785044815500541952 |
---|---|
author | Mustonen, Jyrki Rautiainen, Päivi Lamidi, Marja-Leena Lavikainen, Piia Martikainen, Janne Laatikainen, Tiina |
author_facet | Mustonen, Jyrki Rautiainen, Päivi Lamidi, Marja-Leena Lavikainen, Piia Martikainen, Janne Laatikainen, Tiina |
author_sort | Mustonen, Jyrki |
collection | PubMed |
description | AIMS: To determine the effect of the use of intermittently scanned continuous glucose monitoring (isCGM) on acute diabetes-related complications in adult type 1 diabetes patients. METHODS: Six hundred and forty-two adult type 1 diabetes patients with isCGM were identified from electronic health records in Siun sote region in Eastern Finland. A retrospective real-world analysis was conducted combining hospital admission and prehospital emergency service data to compare incidences of hypoglycemia requiring emergency medical support (EMS) involvement or hospital admission and diabetic ketoacidosis (DKA) before and after the start of isCGM. Data were collected from January 2015 to April 2020. Primary outcome was the rate of hypoglycemia requiring EMS involvement or hospital admission and DKA events. HbA1c was recorded at the start of isCGM and was compared with the last known HbA1c during the use of isCGM. The isCGM used in the study did not contain alarm functions. RESULTS: Altogether 220 hypoglycemic events were identified during the study period. Incidence rate of hypoglycemic events decreased after the start of isCGM (72 events, incidence rate 50 events/1000 person-years) compared with the time before the start (148 events, incidence rate 76 events/1000 person-years) (p = 0.043). The incidence rate of DKA decreased after the start of isCGM compared with time before isCGM use (4 and 15 events/1000 person-years, respectively; p = 0.002). The change in mean HbA1c was − 0.28% (− 3.1 mmol/mol) between baseline and the last HbA1c measurement (p < 0.001). CONCLUSIONS: In addition to lowering HbA1c in type 1 diabetes patients, isCGM is also effective in preventing acute diabetes-related complications such as hypoglycemia requiring EMS involvement or hospital admission and DKA. |
format | Online Article Text |
id | pubmed-10198841 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Milan |
record_format | MEDLINE/PubMed |
spelling | pubmed-101988412023-05-21 The use of isCGM leads to marked reduction in severe hypoglycemia requiring emergency medical service or hospital admission and diabetic ketoacidosis in adult type 1 diabetes patients Mustonen, Jyrki Rautiainen, Päivi Lamidi, Marja-Leena Lavikainen, Piia Martikainen, Janne Laatikainen, Tiina Acta Diabetol Original Article AIMS: To determine the effect of the use of intermittently scanned continuous glucose monitoring (isCGM) on acute diabetes-related complications in adult type 1 diabetes patients. METHODS: Six hundred and forty-two adult type 1 diabetes patients with isCGM were identified from electronic health records in Siun sote region in Eastern Finland. A retrospective real-world analysis was conducted combining hospital admission and prehospital emergency service data to compare incidences of hypoglycemia requiring emergency medical support (EMS) involvement or hospital admission and diabetic ketoacidosis (DKA) before and after the start of isCGM. Data were collected from January 2015 to April 2020. Primary outcome was the rate of hypoglycemia requiring EMS involvement or hospital admission and DKA events. HbA1c was recorded at the start of isCGM and was compared with the last known HbA1c during the use of isCGM. The isCGM used in the study did not contain alarm functions. RESULTS: Altogether 220 hypoglycemic events were identified during the study period. Incidence rate of hypoglycemic events decreased after the start of isCGM (72 events, incidence rate 50 events/1000 person-years) compared with the time before the start (148 events, incidence rate 76 events/1000 person-years) (p = 0.043). The incidence rate of DKA decreased after the start of isCGM compared with time before isCGM use (4 and 15 events/1000 person-years, respectively; p = 0.002). The change in mean HbA1c was − 0.28% (− 3.1 mmol/mol) between baseline and the last HbA1c measurement (p < 0.001). CONCLUSIONS: In addition to lowering HbA1c in type 1 diabetes patients, isCGM is also effective in preventing acute diabetes-related complications such as hypoglycemia requiring EMS involvement or hospital admission and DKA. Springer Milan 2023-03-28 2023 /pmc/articles/PMC10198841/ /pubmed/36977968 http://dx.doi.org/10.1007/s00592-023-02079-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Mustonen, Jyrki Rautiainen, Päivi Lamidi, Marja-Leena Lavikainen, Piia Martikainen, Janne Laatikainen, Tiina The use of isCGM leads to marked reduction in severe hypoglycemia requiring emergency medical service or hospital admission and diabetic ketoacidosis in adult type 1 diabetes patients |
title | The use of isCGM leads to marked reduction in severe hypoglycemia requiring emergency medical service or hospital admission and diabetic ketoacidosis in adult type 1 diabetes patients |
title_full | The use of isCGM leads to marked reduction in severe hypoglycemia requiring emergency medical service or hospital admission and diabetic ketoacidosis in adult type 1 diabetes patients |
title_fullStr | The use of isCGM leads to marked reduction in severe hypoglycemia requiring emergency medical service or hospital admission and diabetic ketoacidosis in adult type 1 diabetes patients |
title_full_unstemmed | The use of isCGM leads to marked reduction in severe hypoglycemia requiring emergency medical service or hospital admission and diabetic ketoacidosis in adult type 1 diabetes patients |
title_short | The use of isCGM leads to marked reduction in severe hypoglycemia requiring emergency medical service or hospital admission and diabetic ketoacidosis in adult type 1 diabetes patients |
title_sort | use of iscgm leads to marked reduction in severe hypoglycemia requiring emergency medical service or hospital admission and diabetic ketoacidosis in adult type 1 diabetes patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198841/ https://www.ncbi.nlm.nih.gov/pubmed/36977968 http://dx.doi.org/10.1007/s00592-023-02079-y |
work_keys_str_mv | AT mustonenjyrki theuseofiscgmleadstomarkedreductioninseverehypoglycemiarequiringemergencymedicalserviceorhospitaladmissionanddiabeticketoacidosisinadulttype1diabetespatients AT rautiainenpaivi theuseofiscgmleadstomarkedreductioninseverehypoglycemiarequiringemergencymedicalserviceorhospitaladmissionanddiabeticketoacidosisinadulttype1diabetespatients AT lamidimarjaleena theuseofiscgmleadstomarkedreductioninseverehypoglycemiarequiringemergencymedicalserviceorhospitaladmissionanddiabeticketoacidosisinadulttype1diabetespatients AT lavikainenpiia theuseofiscgmleadstomarkedreductioninseverehypoglycemiarequiringemergencymedicalserviceorhospitaladmissionanddiabeticketoacidosisinadulttype1diabetespatients AT martikainenjanne theuseofiscgmleadstomarkedreductioninseverehypoglycemiarequiringemergencymedicalserviceorhospitaladmissionanddiabeticketoacidosisinadulttype1diabetespatients AT laatikainentiina theuseofiscgmleadstomarkedreductioninseverehypoglycemiarequiringemergencymedicalserviceorhospitaladmissionanddiabeticketoacidosisinadulttype1diabetespatients AT mustonenjyrki useofiscgmleadstomarkedreductioninseverehypoglycemiarequiringemergencymedicalserviceorhospitaladmissionanddiabeticketoacidosisinadulttype1diabetespatients AT rautiainenpaivi useofiscgmleadstomarkedreductioninseverehypoglycemiarequiringemergencymedicalserviceorhospitaladmissionanddiabeticketoacidosisinadulttype1diabetespatients AT lamidimarjaleena useofiscgmleadstomarkedreductioninseverehypoglycemiarequiringemergencymedicalserviceorhospitaladmissionanddiabeticketoacidosisinadulttype1diabetespatients AT lavikainenpiia useofiscgmleadstomarkedreductioninseverehypoglycemiarequiringemergencymedicalserviceorhospitaladmissionanddiabeticketoacidosisinadulttype1diabetespatients AT martikainenjanne useofiscgmleadstomarkedreductioninseverehypoglycemiarequiringemergencymedicalserviceorhospitaladmissionanddiabeticketoacidosisinadulttype1diabetespatients AT laatikainentiina useofiscgmleadstomarkedreductioninseverehypoglycemiarequiringemergencymedicalserviceorhospitaladmissionanddiabeticketoacidosisinadulttype1diabetespatients |